|
GGB |
Interim MD&A for the Q2 period ended Dec. 28, 2019 |
MD&A (Management Discussion and Analysis) |
26/02/2020 |
 Open Filing (1.49 MB) |
|
GGB |
Q2 Financial Statements for the period ended Dec. 28 2019 |
Interim Financial Statements |
26/02/2020 |
Open Filing (1.05 MB) |
|
GGB |
Form 10 - Notice of Proposed Significant Transaction |
Proposed Transaction |
26/02/2020 |
Open Filing (137.41 KB) |
|
CGN |
CGN - Cognetivity Neurosciences Arranges Convertible Notes |
Press Release |
26/02/2020 |
Open Filing (169.75 KB) |
|
CGN |
CGN - Cognetivity Neurosciences Arranges Convertible Notes |
Press Release |
26/02/2020 |
Open Filing (99.69 KB) |
|
CGN |
CGN - Cognetivity Neurosciences Publishes Key Results From its Integrated Cognitive Assessment Research in Nature Publishing Group Journal Scientific Reports |
Press Release |
26/02/2020 |
Open Filing (221.53 KB) |
|
CGN |
Cognetivity Neurosciences Announces Non-Brokered Private Placement |
Press Release |
26/02/2020 |
Open Filing (201.03 KB) |
|
CGN |
CGN - Cognetivity Neurosciences Closes First Tranche of Non-Brokered Private Placement |
Press Release |
26/02/2020 |
Open Filing (201.05 KB) |
|
CGN |
CGN - Cognetivity Neurosciences to Present Key Research Data Demonstrating its AI Platform’s Unique Ability to Accurately Detect & Monitor Cognitive Impairment in Multiple Sclerosis Patients |
Press Release |
26/02/2020 |
Open Filing (358.63 KB) |
|
CGN |
CGN - Cognetivity Neurosciences’ Chief Medical Officer to Present at Alzheimer’s Association International Conference (AAIC) 2019 |
Press Release |
26/02/2020 |
Open Filing (228.9 KB) |
